Document:

Form of Bridge Warrant, dated as of October 2006

 EXHIBIT 4.34 
  

 2006 BRIDGE WARRANT 
  
 To Purchase Common Stock of 
  
 SYNOVA HEALTHCARE GROUP, INC. 
  

 Original Issue Date: October
    , 2006 

 NEITHER THIS WARRANT NOR ANY OF THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAW. THE WARRANTS REPRESENTED BY THIS CERTIFICATE AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, EXCHANGED,
MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR ENCUMBERED WITHOUT COMPLIANCE WITH THE PROVISIONS OF, AND ARE OTHERWISE RESTRICTED BY THE PROVISIONS OF, THE ACT, THE RULES AND REGULATIONS THEREUNDER AND THIS WARRANT. 
  

			
	Original Issue Date: October     , 2006	 	Warrant No. 2006-            

 2006 BRIDGE WARRANT 
 TO PURCHASE SHARES OF COMMON STOCK 
 OF 
 SYNOVA HEALTHCARE GROUP, INC. 
 THIS
IS TO CERTIFY THAT                      (the “Original Holder”), or his registered assigns, is entitled, at any time
prior to the Expiration Date (such term, and certain other capitalized terms used herein being hereinafter defined), to purchase from Synova Healthcare Group, Inc., a Nevada corporation (the “Company”), those number of shares
of the Common Stock of the Company as provided herein, at a purchase price per share (the “Initial Exercise Price”, subject to adjustment as provided herein) equal to $1.50. This Warrant is one of a series of warrants which may be
issued by the Company and which are designated as the 2006 bridge warrants (collectively, the “2006 Bridge Warrants”). 
 1. Definitions.

 As used in this Warrant, the following terms have the respective meanings set forth below: 
 “2006 Bridge Note” shall mean the 2006 Convertible Bridge Note issued by the Company to the Holders and certain other purchasers.

 “2006 Bridge Warrants” has the meaning set forth in the opening paragraph of this Warrant. 
 “2006 Warrant Stock” shall mean all of the shares of Common Stock issued, issuable or both (as the context may require) upon the
exercise of 2006 Bridge Warrants. 

 “Additional Shares of Common Stock” means all shares of Common Stock issued (or deemed
to be issued as a result of any determination of shares issued on a fully-diluted basis) by the Company after the Original Issue Date, other than shares of Common Stock issued or issuable (i) to officers, directors, employees, strategic
business partners of, or consultants to, the Company pursuant to stock option or stock purchase plans or agreements on terms approved by the Compensation Committee of the Board of Directors or the Board of Directors; or (ii) for which
adjustment of the Exercise Price is made pursuant to Section 4. 
 “Agreed Rate” shall mean the rate of interest
announced publicly by Citibank, N.A. in New York, New York, from time to time, as Citibank, N.A.’s base rate. 
 “Business
Day” shall mean any day that is not a Saturday or Sunday or a day on which banks are required or permitted to be closed in the State of New York. 
 “Common Stock” shall mean the Common Stock of the Company, $.001 par value per share, as constituted on the Original Issue Date, and any capital stock into which such Common Stock may thereafter be
changed, and shall also include (a) capital stock of the Company of any other class (regardless of how denominated) issued to the holders of shares of any Common Stock upon any reclassification thereof which is also not preferred as to
dividends or liquidation over any other class of stock of the Company and which is not subject to redemption, and (b) shares of common stock of any successor or acquiring corporation (as provided in Section 4.5 hereof) received by
or distributed to the holders of Common Stock in the circumstances contemplated by Section 4.5 hereof. 
 “Company” means Synova Healthcare Group, Inc., a Nevada corporation, and any successor corporation. 
 “Designated Office” shall have the meaning set forth in Section 9 hereof. 
 “Exchange
Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated thereunder, all as the same shall be in effect from time to time. 
 “Exercise Date” shall have the meaning set forth in Section 2.1 hereof. 
 “Exercise Notice” shall have the meaning set forth in Section 2.1 hereof. 
 “Exercise Period” shall mean the period during which this Warrant is exercisable pursuant to Section 2.1 hereof. 

“Exercise Price” shall mean, in respect of a share of Common Stock at any date herein specified, the initial Exercise Price set forth
in the preamble of this Warrant as adjusted from time to time pursuant to Section 4 hereof. 
 “Expiration Date”
shall mean the second anniversary of the Original Issue Date. 
  

 2 

 “Fair Market Value” per share of Common Stock as of any specified date shall mean
(a) if the Common Stock is publicly traded on such date, the then current market price per share or (b) if the Common Stock is not publicly traded on such date, (i) the fair market value per share of Common Stock as determined in good
faith by the Board of Directors of the Company and set forth in a written notice to each Holder or (ii) if the Majority 2006 Bridge Warrant Holders object in writing to such price as determined by the Board of Directors within thirty
(30) days after receiving notice of same, the appraised value per share as of such date, as determined by an investment bank chosen by the Majority 2006 Bridge Warrant Holders, the cost of which will be shared equally by the Company and the
Majority 2006 Bridge Warrant Holders. 
 “GAAP” shall mean generally accepted accounting principles set forth in the
opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board, which are in effect from time to time.

 “Holder” shall mean (a) with respect to this Warrant, the Person in whose name this Warrant is registered on the
books of the Company maintained for such purpose and (b) with respect to shares of Warrant Stock, the Person in whose name such Warrant Stock is registered on the books of the Company maintained for such purpose. 
 “Lien” shall mean any mortgage or deed of trust, pledge, hypothecation, assignment, deposit arrangement, lien, charge, claim, security
interest, easement or encumbrance, or preference, priority or other security agreement or preferential arrangement of any kind or nature whatsoever (including, without limitation, any lease or title retention agreement, any financing lease having
substantially the same economic effect as any of the foregoing, and the filing of, or agreement to give, any financing statement perfecting a security interest under the Uniform Commercial Code or comparable law of any jurisdiction). 
 “Majority 2006 Bridge Warrant Holders” means, with respect to a given determination, shall mean the holders of 2006 Bridge Warrants
exercisable for more than fifty percent (50%) of the 2006 Warrant Stock issuable upon the exercise of all then outstanding 2006 Bridge Warrants. 
 “Opinion of Counsel” shall mean a written opinion of outside counsel experienced in Securities Act matters chosen by the Holder of this Warrant or Warrant Stock issued upon the exercise hereof.

 “Original Issue Date” shall mean the date on which this Warrant was issued, as set forth on the cover page of this
Warrant. 
 “Outstanding” shall mean, when used with reference to Common Stock, at any date as of which the number of shares
thereof is to be determined, all issued shares of Common Stock, except shares then owned or held by or for the account of the Company or any Subsidiary, and shall include all shares issuable in respect of outstanding scrip or any certificates
representing fractional interests in shares of Common Stock. 
  

 3 

 “Person” shall mean any individual, sole proprietorship, partnership, limited liability
company, joint venture, trust, incorporated organization, association, corporation, institution, public benefit corporation, entity or government (whether federal, state, county, city, municipal or otherwise, including, without limitation, any
instrumentality, division, agency, body or department thereof). 
 “Restricted Common Stock” shall mean shares of Common
Stock which are, or which upon their issuance on the exercise of this Warrant would be, evidenced by a certificate bearing the restrictive legend set forth in Section 8.2(a) hereof. 
 “SEC” shall mean the Securities and Exchange Commission, or any other federal agency then administering the Securities Act and other
federal securities laws. 
 “Securities Act” shall mean the Securities Act of 1933, as amended, and the rules and
regulations of the SEC promulgated thereunder, all as the same shall be in effect at the time. 
 “Subsidiary” shall mean
any corporation, association or other business entity (a) at least 50% of the outstanding voting securities of which are at the time owned or controlled directly or indirectly by the Company, or (b) with respect to which the Company
possesses, directly or indirectly, the power to direct or cause the direction of the affairs or management of such person. 
 “Transfer” shall mean any disposition of any Warrant or Warrant Stock or of any interest therein, which would constitute a “sale” thereof or a transfer of a beneficial interest therein within the meaning of the
Securities Act. 
 “Warrant” and “Warrants” shall mean this Warrant and all Warrants issued upon transfer,
division or combination of, or in substitution for, this Warrant. 
 “Warrant Price” shall mean an amount equal to
(a) the number of shares of Common Stock being purchased upon exercise of this Warrant pursuant to Section 2.1 hereof, multiplied by (b) the Exercise Price as of the date of such exercise. The Warrant Price paid shall be
rounded upward or downward to the nearest whole cent. 
 “Warrant Stock” shall mean the shares of Common Stock issued,
issuable or both (as the context may require) upon the exercise of Warrants. 
 2. Exercise Of Warrant. 
 2.1. Manner of Exercise. 
 (a) From and
after the Original Issue Date, and until 5:00 P.M., Eastern Time, on the Expiration Date, the Holder of this Warrant may from time to time exercise this Warrant, on any Business Day, for all or any part of the number of shares of Common Stock
purchasable hereunder. In order to exercise this Warrant, in whole or in part, the Holder shall (i) deliver to the Company at its Designated Office a written notice of the Holder’s election to exercise this Warrant (an “Exercise
Notice”), which Exercise Notice shall be irrevocable and specify the 

  

 4 

 
number of shares of Common Stock to be purchased pursuant to this Warrant, and (ii) pay to the Company the Warrant Price (the date on which both such
delivery and payment shall have first taken place being hereinafter sometimes referred to as the “Exercise Date”). Such Exercise Notice shall be in the form of the subscription form appearing at the end of this Warrant as Annex
A, duly executed by the Holder or its duly authorized agent or attorney. 
 (b) The Company shall issue to the Holder a number of Shares
of Common Stock calculated on the basis of the following formula: (i) the original principal amount of the 2006 Bridge issued to the Original Holder multiplied by thirty percent (30%) divided by (ii) the Exercise Price.

 (c) Upon receipt by the Company of the Exercise Notice, Warrant and payment, the Company shall, as promptly as practicable, and in any
event within five (5) Business Days thereafter, execute (or cause to be executed) and deliver (or cause to be delivered) to the Holder a certificate or certificates representing the aggregate number of full shares of Common Stock issuable upon
such exercise, together with cash in lieu of any fraction of a share, as hereafter provided. The stock certificate or certificates so delivered shall be in such denomination or denominations as the exercising Holder shall request in the Exercise
Notice and shall be registered in the name of the Holder or, subject to Section 8 below, such other name as shall be designated in the Exercise Notice. This Warrant shall be deemed to have been exercised and such certificate or
certificates shall be deemed to have been issued, and the Holder or any other Person so designated to be named therein shall be deemed to have become a holder of record of such shares for all purposes, as of the Exercise Date. 
 (d) Payment of the Warrant Price shall be made at the option of the Holder by delivery of a certified or official bank check in the amount of such
Warrant Price payable to the order of the Company or by wire transfer. 
 (e) If this Warrant shall have been exercised in part, the Company
shall, at the time of delivery of the certificate or certificates representing the shares of Common Stock being issued, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased shares of Common Stock called
for by this Warrant. Such new Warrant shall in all other respects be identical to this Warrant. 
 (f) Subject to the provisions of
Sections 2.1(d), all Warrants delivered for exercise shall be canceled by the Company. 
 2.2. Payment of Taxes. All shares of
Common Stock issuable upon the exercise of this Warrant pursuant to the terms hereof shall be validly issued, fully paid and nonassessable, issued without violation of any preemptive rights and free and clear of all Liens. The Company shall pay all
expenses in connection with, and all taxes and other governmental charges that may be imposed with respect to, the issue or delivery thereof, unless such tax or charge is imposed by law upon the Holder, in which case such taxes or charges shall be
paid by the Holder and the Company shall reimburse the Holder therefor on an after-tax basis. 
 2.3. Fractional Shares. The Company
shall not be required to issue a fractional share of Common Stock upon exercise of any Warrant. As to any fraction of a share that the Holder of 

  

 5 

 
one or more Warrants, the rights under which are exercised in the same transaction, would otherwise be entitled to purchase upon such exercise, the Company
shall pay to such Holder an amount in cash equal to such fraction multiplied by the Fair Market Value of one share of Common Stock on the Exercise Date. 
 3. Transfer, Division And Combination. 
 3.1. Transfer. Subject to compliance with Section 8 hereof, each
transfer of this Warrant and all rights hereunder, in whole or in part, shall be registered on the books of the Company to be maintained for such purpose, upon surrender of this Warrant at the Designated Office, together with a written assignment of
this Warrant in the form of Annex B hereto duly executed by the Holder or its agent or attorney. Upon such surrender and delivery the Company shall, subject to Section 8, execute and deliver a new Warrant or Warrants in the name
of the assignee or assignees and in the denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned and this Warrant shall promptly be canceled. A
Warrant, if properly assigned in compliance with Section 8, may be exercised by the new Holder for the purchase of shares of Common Stock without having a new Warrant issued. 
 3.2. Division and Combination. Subject to compliance with the applicable provisions of this Warrant, including, without limitation,
Section 8, this Warrant may be divided or combined with other Warrants upon presentation thereof at the Designated Office, together with a written notice specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney. Subject to compliance with the applicable provisions of this Warrant as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or
Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. 
 3.3. Expenses. The
Company shall prepare, issue and deliver at its own expense any new Warrant or Warrants required to be issued under this Section 3. 
 3.4. Maintenance of Books. The Company agrees to maintain, at the Designated Office, books for the registration and transfer of the Warrants. 
 4. Antidilution Provisions. 
 The number of shares of Common Stock for which this Warrant is exercisable, and the Exercise
Price, shall be subject to adjustment from time to time as set forth in this Section 4. 
 4.1. Upon Stock Dividends,
Subdivisions or Splits. If, at any time after the Original Issue Date, the number of shares of Common Stock outstanding is increased by a stock dividend payable in shares of Common Stock or by a subdivision or split-up of shares of Common Stock,
then, following the record date for the determination of holders of Common Stock entitled to receive such stock dividend, or to be affected by such subdivision or split-up, the Exercise Price shall be appropriately decreased so that the number of
shares of Common Stock issuable on exercise of the Warrant shall be increased in proportion to such increase in outstanding shares. 
  

 6 

 4.2. Upon Combinations. If, at any time after the Original Issue Date, the number of shares of
Common Stock outstanding is decreased by a combination of the outstanding shares of Common Stock into a smaller number of shares of Common Stock, then, following the record date to determine shares affected by such combination, the Exercise Price
shall be appropriately increased and the number of shares of Common Stock issuable on exercise of the Warrant shall be appropriately decreased in proportion to such decrease in outstanding shares. 
 4.3. Upon Reclassifications, Reorganizations, Consolidations or Mergers. In the event of any capital reorganization of the Company, any
reclassification of the stock of the Company (other than a change in par value or from par value to no par value or from no par value to par value or as a result of a stock dividend or subdivision, split-up or combination of shares), or any
consolidation or merger of the Company with or into another corporation (where the Company is not the surviving corporation or where there is a change in or distribution with respect to the Common Stock), the Warrant shall after such reorganization,
reclassification, consolidation, or merger be exercisable for the kind and number of shares of stock or other securities or property of the Company or of the successor corporation resulting from such consolidation or surviving such merger, if any,
to which the holder of the number of shares of Common Stock deliverable (immediately prior to the time of such reorganization, reclassification, consolidation or merger) upon exercise of such Warrant would have been entitled upon such
reorganization, reclassification, consolidation or merger. The provisions of this clause shall similarly apply to successive reorganizations, reclassifications, consolidations, or mergers. 
 4.4. Deferral in Certain Circumstances. In any case in which the provisions of this Section 4 shall require that an adjustment shall
become effective immediately after a record date of an event, the Company may defer until the occurrence of such event issuing to the Holder of the Warrant exercised after such record date and before the occurrence of such event the shares of
capital stock issuable upon such conversion by reason of the adjustment required by such event and issue to such holder only the shares of capital stock issuable upon such conversion before giving effect to such adjustments, provided, however, that
the Company shall deliver to such holder an appropriate instrument or due bills evidencing such holder’s right to receive such additional shares. 
 4.5. Notice of Adjustment of Exercise Price. Whenever the Exercise Price is adjusted as herein provided: 
 (i) the Company shall compute the adjusted Exercise Price in accordance with Section 4 and shall prepare a certificate signed by the Controller or Chief Financial Officer of the Company setting forth the adjusted Exercise Price
and number of shares of Common Stock for which this Warrant is exercisable and showing in reasonable detail the facts upon which such adjustment is based, and such certificate shall forthwith be filed at each office or agency maintained for such
purpose; and 
 (ii) a notice stating that the Exercise Price and number of shares of Common Stock for which this Warrant is exercisable has
been adjusted and setting forth the adjusted Exercise Price and such adjusted number of shares shall forthwith be prepared by the Company, and as soon as practicable after it is prepared, such notice shall be mailed by the Company at its expense to
all holders at their last addresses as they shall appear in the Warrant register. 
  

 7 

 4.6. Adjustment of Number of Shares Purchasable. Upon any adjustment of the Exercise Price as
provided in this Section 4, the holders of the Warrants shall thereafter be entitled to purchase upon the exercise thereof, at the Exercise Price resulting from such adjustment, the number of shares of Common Stock (calculated to the
nearest 1/100th of a share) obtained by multiplying the Exercise Price in effect immediately prior to such adjustment by the number of shares of Common Stock issuable on the exercise hereof immediately prior to such adjustment and dividing the
product thereof by the Exercise Price resulting from such adjustment. 
 5. No Impairment; Regulatory Compliance And Cooperation; Notice Of Expiration.

 5.1. No Impairment; Regulatory Compliance and Cooperation. The Company shall not by any action, including, without limitation,
amending its charter documents or through any reorganization, reclassification, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other similar voluntary action, avoid or seek to avoid the observance or
performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of the Holder against
impairment. Without limiting the generality of the foregoing, the Company shall take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon
the exercise of this Warrant, free and clear of all Liens, and shall use its best efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof as may be necessary to enable the Company
to perform its obligations under this Warrant. 
 5.2. Notice of Expiration. The Company shall deliver to each Holder of Warrants on
or before six months prior to the Expiration Date, but no earlier than nine months prior to the Expiration Date, advance notice of such Expiration Date. 
 6. Reservation And Authorization Of Common Stock; Registration With Or Approval Of Any Governmental Authority. 
 From and
after the Original Issue Date, the Company shall at all times reserve and keep available for issuance upon the exercise of the Warrants such number of its authorized but unissued shares of Common Stock as will be sufficient to permit the exercise in
full of all outstanding Warrants. All shares of Common Stock issuable pursuant to the terms hereof, when issued upon exercise of this Warrant with payment therefor in accordance with the terms hereof, shall be duly and validly issued and fully paid
and nonassessable, not subject to preemptive rights and shall be free and clear of all Liens. Before taking any action that would result in an adjustment in the number of shares of Common Stock for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction over such action. If any shares of Common Stock required
to be reserved for issuance upon exercise of Warrants require registration or qualification with any governmental authority under any federal or state law (other than under the Securities Act or any state securities law) before such shares may be so
issued, the Company will in good faith and as expeditiously as possible and at its expense endeavor to cause such shares to be duly registered. 
  

 8 

 7. Notice Of Corporate Actions; Taking Of Record; Transfer Books. 
 7.1. Notices of Corporate Actions. In case: 
 (a) the Company shall take an action or an event shall occur, that would require an Exercise Price adjustment pursuant to Section 4; 
 (b) the Company shall grant to the holders of its Common Stock or any other class of stocks or securities of the Company rights or warrants to subscribe for or purchase any shares of capital stock of any class;

 (c) of any reclassification of the Common Stock or any other class of stocks or securities of the Company, or of any consolidation,
merger or share exchange to which the Company is a party and for which approval of any stockholders of the Company is required, or of the sale or transfer of all or substantially all of the assets of the Company; 
 (d) of the voluntary or involuntary dissolution, liquidation or winding up of the Company; or 
 (e) the Company or any Subsidiary shall commence a tender offer for all or a portion of the outstanding shares of Common Stock (or any other class of
stocks or securities of the Company, or shall amend any such tender offer to change the maximum number of shares being sought or the amount or type of consideration being offered therefor); 
 then the Company shall cause to be filed at each office or agency maintained for such purpose, and shall cause to be mailed to all holders at their last
addresses as they shall appear in the Warrant register, at least 10 days prior to the applicable record, effective or expiration date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution or granting of rights or warrants, or, if a record is not to be taken, the date as of which the holders of Common Stock, or such other holders of securities of the Company of record who will be entitled to such dividend,
distribution, rights or warrants are to be determined, (y) the date on which such reclassification, consolidation, merger, share exchange, sale, transfer, dissolution, liquidation or winding up is expected to become effective, and the date as
of which it is expected that holders of Common Stock, or such other holders of securities of the Company of record shall be entitled to exchange their shares of Common Stock, or such other securities for securities, cash or other property
deliverable upon such reclassification, consolidation, merger, share exchange, sale, transfer, dissolution, liquidation or winding up, or (z) the date on which such tender offer commenced, the date on which such tender offer is scheduled to
expire unless extended, the consideration offered and the other material terms thereof (or the material terms of the amendment thereto). Such notice shall also set forth such facts with respect thereto as shall be reasonably necessary to indicate
the effect of such action on the Exercise Price and the number and kind or class of shares or other securities or property which shall be deliverable or purchasable upon the occurrence of such action or deliverable upon exercise of the Warrants.
Neither the failure to give any such notice nor any defect therein shall affect the legality or validity of any action described in clauses (a) through (e) of this Section 7.1. 
  

 9 

 7.2. Taking of Record. In the case of all dividends or other distributions by the Company to the
holders of its Common Stock or any preferred stock with respect to which any provision of any Section hereof refers to the taking of a record of such holders, the Company will in each such case take such a record and will take such record as of the
close of business on a Business Day. 
 7.3. Closing of Transfer Books. The Company shall not at any time, except upon dissolution,
liquidation or winding up of the Company, close its stock transfer books or Warrant transfer books so as to result in preventing or delaying the exercise or transfer of any Warrant. 
 8. Transfer Restrictions. 
 The Holder, by acceptance of this Warrant, agrees to be bound by the
provisions of this Section 8. 
 8.1. Restrictions on Transfers. Neither this Warrant nor any shares of Restricted Common
Stock issued upon the exercise hereof shall be transferred, sold, assigned, exchanged, mortgaged, pledged, hypothecated or otherwise disposed of or encumbered without compliance with the provisions of, and are otherwise restricted by the provisions
of, the Securities Act and this Warrant. Each certificate, if any, evidencing such shares of Restricted Common Stock issued upon any such Transfer, other than in a public offering pursuant to an effective registration statement, shall bear the
restrictive legend set forth in Section 8.2(a), and each Warrant issued upon such Transfer shall bear the restrictive legend set forth in Section 8.2(b), unless the Holder delivers to the Company an Opinion of Counsel to the
effect that such legend is not required for the purposes of compliance with the Securities Act. Holders of the Warrants or the Restricted Common Stock, as the case may be, shall not be entitled to Transfer such Warrants or such Restricted Common
Stock except in accordance with this Section 8.1. 
 8.2. Restrictive Legends. (a) Except as otherwise provided in
this Section 8, each certificate for Warrant Stock initially issued upon the exercise of this Warrant, and each certificate for Warrant Stock issued to any subsequent transferee of any such certificate, shall be stamped or otherwise
imprinted with two legends in substantially the following forms: 
 “THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAW. THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, EXCHANGE, MORTGAGE, PLEDGED, HYPOTHECATED OF OTHERWISE
DISPOSED OF OR ENCUMBERED WITHOUT COMPLIANCE WITH THE PROVISIONS OF, AND ARE OTHERWISE RESTRICTED BY THE PROVISIONS OF, THE ACT AND THE RULES AND REGULATIONS THEREUNDER.” 
  

 10 

 “THE SHARES REPRESENTED BY THIS CERTIFICATE ARE ENTITLED TO THE BENEFIT OF, AND ARE SUBJECT TO
CERTAIN OBLIGATIONS SET FORTH IN, A CERTAIN WARRANT, DATED JULY     , 2006, ORIGINALLY ISSUED BY SYNOVA HEALTHCARE GROUP, INC. (THE “WARRANT”), PURSUANT TO THE EXERCISE OF WHICH SUCH SHARES WERE ISSUED. A
COPY OF THE WARRANT IS AVAILABLE AT THE EXECUTIVE OFFICES OF SYNOVA HEALTHCARE GROUP, INC.” 
 (b) Except as otherwise provided in this
Section 8, each Warrant shall be stamped or otherwise imprinted with a legend in substantially the following form: 
 “NEITHER THIS WARRANT NOR ANY OF THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAW. THE WARRANT REPRESENTED BY THIS
CERTIFICATE, AND THE STOCK ISSUABLE UPON EXERCISE HEREOF, MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, EXCHANGED, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF OR ENCUMBERED WITHOUT COMPLIANCE WITH THE PROVISIONS OF, AND ARE OTHERWISE
RESTRICTED BY THE PROVISIONS OF, THE ACT, THE RULES AND REGULATIONS THEREUNDER AND THIS WARRANT.” 
 8.3. Termination of Securities
Law Restrictions. Notwithstanding the foregoing provisions of this Section 8, the restrictions imposed by Section 8.1 upon the transferability of this Warrant and the Restricted Common Stock and the legend requirements of
Section 8.2 shall terminate as to any particular Warrant or shares of Restricted Common Stock when the Company shall have received from the Holder thereof an Opinion of Counsel to the effect that such legend is not required in order to
ensure compliance with the Securities Act. Whenever the restrictions imposed by Sections 8.1 and 8.2 shall terminate as to this Warrant, as hereinabove provided, the Holder hereof shall be entitled to receive from the Company, at the
expense of the Company, a new Warrant bearing the following legend in place of the restrictive legend set forth hereon: 
 “THE
RESTRICTIONS ON TRANSFERABILITY OF THE WITHIN WARRANT CONTAINED IN SECTIONS 8.1 AND 8.2 HEREOF TERMINATED ON
                    , 200  , AND ARE OF NO FURTHER FORCE AND EFFECT.” 
 All Warrants issued upon registration of transfer, division or combination of, or in substitution for, any Warrant or Warrants entitled to bear such
legend shall have a similar legend endorsed thereon. Whenever the restrictions imposed by this Section 8 shall terminate as to any share of Restricted Common Stock, as hereinabove provided, the Holder thereof shall be entitled to receive
from the Company, at the Company’s expense, a new certificate representing such Common Stock not bearing the restrictive legend set forth in Section 8.2(a). 
  

 11 

 8.4. Representation. The holder of this Warrant, by acceptance hereof, acknowledges that this
Warrant and the shares of Common Stock to be issued upon exercise hereof or conversion thereof are being acquired solely for the holder’s own account and not as a nominee for any other party and for investment, and that the holder will not
offer, sell or otherwise dispose of this Warrant or any shares of Common Stock to be issued upon exercise hereof except under circumstances that will not result in a violation of the Securities Act of 1933, as amended, or any state securities laws.
Upon exercise of this Warrant, the Holder shall, if requested by the Company, confirm in writing, in form satisfactory to the Company, that the shares of Common Stock so purchased are being acquired by an “accredited investor” solely for
such purchaser’s own account and not as a nominee for any other party, for investment, and not with a view toward distribution or resale. 
 9.
Office Of The Company. 
 As long as any of the Warrants remain outstanding, the Company shall maintain an office or agency, which may be
the principal executive offices of the Company (the “Designated Office”), where the Warrants may be presented for exercise, registration of transfer, division or combination as provided in this Warrant. Such Designated Office shall
initially be the office of the Company at 1400 North Providence Road, Building II, Suite 6010, Media, Pennsylvania 19063. The Company may from time to time change the Designated Office to another office of the Company or its agent within the United
States by written notice given to all registered Holders at least ten (10) Business Days prior to the effective date of such change. 
 10. Dividends
On Common Stock. 
 In the event any dividend is declared with respect to the Common Stock of the Company, the Company shall give the
holder of this Warrant as not less than (30) days prior written notice of the record date established by the Board of Directors for such dividend in order to provide the holder with sufficient time to determine whether to exercise this Warrant
as of a date prior to the record date and receive such dividend. 
 11. Miscellaneous. 
 11.1. Non-waiver. No course of dealing or any delay or failure to exercise any right hereunder on the part of the Company or the Holder shall
operate as a waiver of such right or otherwise prejudice the rights, powers or remedies of such Person. 
 11.2. Notice Generally. Any
notice, demand, request, consent, approval, declaration, delivery or communication hereunder to be made pursuant to the provisions of this Warrant shall be sufficiently given or made if in writing and either delivered in person with receipt
acknowledged, sent by a recognized overnight courier service, or sent by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 
 (a) if to any Holder of this Warrant or of Warrant Stock issued upon the exercise hereof, at its last known address appearing on the books of the Company maintained for such purpose; 
 (b) if to the Company, at the Designated Office; 
  

 12 

 or at such other address as may be substituted by notice given as herein provided. The giving of any notice required
hereunder may be waived in writing by the party entitled to receive such notice. Every notice, demand, request, consent, approval, declaration, delivery or other communication hereunder shall be deemed to have been duly given or served on the date
on which personally delivered, with receipt acknowledged, or three (3) Business Days after the same shall have been deposited in the United States mail, or one (1) Business Day after the same shall have been sent by Federal Express or
another recognized overnight courier service. 
 11.3. Indemnification. The Company shall indemnify, save and hold harmless the Holder
hereof and the Holders of any Warrant Stock issued upon the exercise hereof from and against any and all liability, loss, cost, damage, reasonable attorneys’ and accountants’ fees and expenses, court costs and all other out-of-pocket
expenses incurred in connection with or arising from any default hereunder by the Company. This indemnification provision shall be in addition to the rights of such Holder or Holders to bring an action against the Company for breach of contract
based on such default hereunder. 
 11.4. Limitation of Liability. No provision hereof, in the absence of affirmative action by the
Holder to purchase shares of Common Stock, and no enumeration herein of the rights or privileges of the Holder hereof, shall give rise to any liability of such Holder to pay the Exercise Price for any Warrant Stock other than pursuant to an exercise
of this Warrant or any liability as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company. 
 11.5. Remedies. Each Holder of Warrants and/or Warrant Stock, in addition to being entitled to exercise its rights granted by law, including recovery of damages, shall be entitled to specific performance of its rights provided under
this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees, in an action for specific performance, to waive the
defense that a remedy at law would be adequate. 
 11.6. Successors and Assigns. Subject to the provisions of
Sections 3.1, 8.1 and 8.2, this Warrant and the rights evidenced hereby shall inure to the benefit of and be binding upon the successors of the Company and the permitted successors and assigns of the Holder hereof. The
provisions of this Warrant are intended to be for the benefit of all Holders from time to time of this Warrant and to the extent applicable, all Holders of shares of Warrant Stock issued upon the exercise hereof (including transferees), and shall be
enforceable by any such Holder. 
 11.7. Amendment. This Warrant and all other Warrants may be modified or amended or the provisions
hereof waived with the written consent of the Company and the Majority 2006 Bridge Warrant Holders; provided, that no such Warrant may be modified or amended to reduce the number of shares of Common Stock for which such Warrant is exercisable
or to increase the price at which such shares may be purchased upon exercise of such Warrant (before giving effect to any adjustment as provided therein) without the prior written consent of the Holder thereof. 
  

 13 

 11.8. Severability. Wherever possible, each provision of this Warrant shall be interpreted in such
manner as to be effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provision or the remaining provisions of this Warrant. 
 11.9. Loss or Mutilation. Upon receipt by
the Company from any Holder of evidence reasonably satisfactory to it of the ownership of and the loss, theft, destruction or mutilation of this Warrant and an indemnity reasonably satisfactory to it (it being understood that the written
indemnification agreement of/or affidavit of loss of the Original Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender and cancellation hereof, the Company will execute and deliver in lieu hereof a new Warrant of like
tenor to such Holder; provided, however, that, in the case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company for cancellation. 
 11.10. Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of
this Warrant. 
 11.11. GOVERNING LAW; JURISDICTION. IN ALL RESPECTS, INCLUDING ALL MATTERS OF CONSTRUCTION, VALIDITY AND PERFORMANCE,
THIS WARRANT AND THE OBLIGATIONS ARISING HEREUNDER SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE COMMONWEALTH OF PENNSYLVANIA APPLICABLE TO CONTRACTS MADE AND PERFORMED IN SUCH STATE. THE COMPANY HEREBY
CONSENTS AND AGREES THAT THE STATE OR FEDERAL COURTS LOCATED IN MONTGOMERY COUNTY, PENNSYLVANIA, SHALL HAVE, EXCEPT AS SET FORTH BELOW, EXCLUSIVE JURISDICTION TO HEAR AND DETERMINE ANY CLAIMS OR DISPUTES BETWEEN THE COMPANY AND THE HOLDER OF THIS
WARRANT PERTAINING TO THIS WARRANT OR TO ANY MATTER ARISING OUT OF OR RELATING TO THIS AGREEMENT. 
 11.12. No Rights As A
Stockholder. No rights as a stockholder of the Company shall accrue to the Holder of this Warrant until such Warrant is exercised in accordance with the provisions hereof. 
 [Remainder of Page Intentionally Blank] 
  

 14 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed and its corporate seal
to be impressed hereon and attested by its Secretary or an Assistant Secretary. 
  

			
	THE COMPANY:
	
	Synova Healthcare Group, Inc.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  

			
	[SEAL]
	
	Attest:
		
	By:	 	  

	Name:	 	  

	Title:	 	  

  

 15 

 ANNEX A 
 SUBSCRIPTION FORM 
 [To be executed only upon exercise of Warrant] 
 The undersigned registered owner of this Warrant irrevocably exercises this Warrant for the purchase of
             shares Common Stock of Synova Healthcare Group, Inc. and herewith makes payment therefor in
            , all at the price and on the terms and conditions specified in this Warrant and requests that certificates for the shares of Common Stock hereby purchased (and any
securities or other property issuable upon such exercise) be issued in the name of and delivered to             whose address is
             and, if such shares of Common Stock shall not include all of the shares of Common Stock issuable as provided in this Warrant, that a new Warrant of like tenor and date
for the balance of the shares of Common Stock issuable hereunder be delivered to the undersigned. 
  

	
	  

	(Name of Registered Owner)
	
	  

	(Signature of Registered Owner)
	
	  

	(Street Address)
	
	  

	(City) (State) (Zip Code)
	
	  

	(Warrant No.)

  

			
	NOTICE:	 	The signature on this subscription must correspond with the name as written upon the face of the within Warrant in every particular, without alteration or enlargement or any change
whatsoever.

 ANNEX B 
 ASSIGNMENT FORM 
 FOR VALUE RECEIVED the undersigned registered owner of this Warrant hereby sells,
assigns and transfers unto the assignee named below all of the rights of the undersigned under this Warrant, with respect to the number of shares of Common Stock set forth below: 
  

			
	 Name and Address of Assignee
	  	 Number of Shares
 of Common Stock

		
	  
	  	  

		
	  
	  	  

		
	  
	  	  

 and does hereby irrevocably constitute and appoint
             attorney-in-fact to register such transfer onto the books of Synova Healthcare Group, Inc. maintained for the purpose, with full power of substitution in the premises.

  

			
	Dated:__________________	  	Print Name:__________________
		
		  	Signature:___________________
		
		  	Witness:____________________
		
		  	Warrant No.:_________________

  

			
	NOTICE:	 	The signature on this assignment must correspond with the name as written upon the face of the within Warrant in every particular, without alteration or enlargement or any change
whatsoever.Form of Registration Rights Agreement, dated as of October 2006

 EXHIBIT 4.35 
 REGISTRATION RIGHTS AGREEMENT 
 This Registration Rights Agreement (this
“Agreement”), is made and entered into as of October     , 2006, by and among Synova Healthcare Group, Inc., a Nevada corporation (the “Company”), and the purchaser signatory hereto
(“Purchaser”). 
 This Agreement is made pursuant to the Convertible Note Purchase Agreement, dated as of the date hereof
whereby the Purchaser purchased a $500,000 Note and pursuant to the to the Convertible Note Purchase Agreement (the “Purchase Agreement”). 
 The Company and the Purchasers hereby agree as follows: 
 1. Definitions. Capitalized terms used and
not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings: 
 “Advice” shall have the meaning set forth in Section 7(d). 
 “Commission” means the United States Securities and Exchange Commission or its successor federal agency. 
 “Electing Holder” shall have the meaning set forth in Section 4(a). 
 “Holder” means any person that is the record owner of Registrable Securities (and includes any person that has a beneficial interest in
any Registrable Security in book-entry form). 
 “Holders” mean every Holder collectively. 
 “Indemnified Party” shall have the meaning set forth in Section 6(c). 
 “Indemnifying Party” shall have the meaning set forth in Section 6(c). 
 “Losses” shall have the meaning set forth in Section 6(a). 
 “Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial
proceeding, such as a deposition), whether commenced or threatened. 
 “Prospectus” means the prospectus included in the
Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the Securities
Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by the Registration Statement, and all other amendments and supplements to the Prospectus,
including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such Prospectus. 

 “Registrable Securities” means all of the Note Shares and the Warrant Shares, together
with any shares of Common Stock issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing. 
 “Registration Statement” means the registration statements required to be filed hereunder, including (in each case) the Prospectus, amendments and supplements to the registration statement or
Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to be incorporated by reference in the registration statement. 
 “Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule. 
 “Securities Act” shall mean the Securities Act of 1933, as amended. 
 2. Demand Registration. 

(a) If the Company fails to complete the Subsequent Offering (as defined in the Note) by October 31, 2006, then upon written notice (a
“Demand”) from a Holder or Holders requesting that the Company effect the registration under the Securities Act of any or all of the Registrable Securities held by such Holder or Holders, which notice shall specify the intended
method or methods of disposition of such Registrable Securities, the Company shall, within ten (10) days after receiving the Holder’s or Holders’ Demand, give written notice (the “Request Notice”) of such registration
request to all other Holders. The Request Notice shall offer to each such Holder the opportunity to include in such registration statement such number of Registrable Securities as each such Holder may request within ten (10) days after the date
of the Request Notice, subject to the limitations of this Section 2 and the other provisions of this Agreement. As promptly as possible after such ten (10) day period, the Company shall use its Best Efforts to effect, in the manner set
forth in Section 4 hereof, the registration under the Securities Act of all such Registrable Securities for disposition in accordance with the intended method or methods of disposition stated in the Holder’s or Holders’ request,
provided that: 
 (i) while a registration request is pending pursuant to this Section 2(a), the Company, with the prior approval of a
majority of the Company’s Board of Directors, may delay commencing to effect such registration until 60 days after receipt of notice of such request if the Board of Directors determines, in good faith, that the filing of a registration
statement at the time of such request would be materially detrimental to the Company such that such filing would have a material adverse effect upon the ability of the Company to consummate a material acquisition or other comparable extraordinary
transaction, provided that the Company shall not be permitted to delay a requested registration in reliance on this clause (i) more than once in any twelve (12) month period; and 
 (ii) the Company shall not be obligated to file a registration statement relating to a registration request pursuant to this Section 2(a) within a
period of two (2) months after the effective date of any other registration statement of the Company demanded pursuant to this Section 2(a). 
  

 2 

 (b) In the event that any registration pursuant to this Section 2 shall involve, in whole or in
part, an underwritten offering, the Holder initiating the demand pursuant to Section 2(a) shall have the right to designate an underwriter as the sole lead managing underwriter of such underwritten offering, subject to the Company’s
consent which shall not be unreasonably withheld. 
 3. Piggyback Registration. 
 (a) Subject to Section 3(b) below, if at any time the Company proposes to file or files a Registration Statement under the Securities Act with
respect to any offering of securities of the same type as the Registrable Securities for its own account (other than a Registration Statement on Form S-8 or Form S-4 or any successor form thereto), or for the account of any security holder of
securities of the same type as the Registrable Securities, then, as promptly as practicable, the Company shall give written notice of such proposed filing to each Holder and such notice shall offer the Holders the opportunity to include in such
registration such number of Registrable Securities as each such Holder may request (a “Piggyback Registration”). The Company shall include in such Registration Statement all Registrable Securities requested by a Holder in writing
within ten (10) calendar days after the delivery of any such notice (which Holder’s request shall specify the number of Registrable Securities intended to be disposed of by such Holder) to be included in the registration for such offering
pursuant to a Piggyback Registration. Each Holder electing to participate in such Piggyback Registration shall be subject to all of the terms of such proposed registration and shall execute such usual and customary custody agreements, powers of
attorney, underwriting agreements or other documents as are reasonably requested or required by the Company and any underwriter of such offering. Notwithstanding anything to the contrary contained herein, (i) no Holder hereunder shall have any
registration rights with respect to, or be permitted to include any Registrable Securities on, the Company’s previously-filed Registration Statements on Form SB-2 (Commission File Nos. 333-123498 and 333-134085) and (ii) no Holder of
Registrable Securities shall be permitted to register any Registrable Securities pursuant to the provisions hereof if such Holder may sell all of the Registrable Securities beneficially owned by such Holder under Rule 144 under the Securities Act
within a single three month period. 
 (b) The Company shall use its best efforts to cause the managing underwriter or underwriters of a
proposed public offering to permit the Registrable Securities requested to be included in the registration for such offering under Sections 2(a) or 3(a) above to be included on the same terms and conditions as any similar securities included
therein. Notwithstanding the foregoing, if the managing underwriter or underwriters participating in such offering advises each of the Holders in writing (with a copy to the Company) that the total amount of securities requested to be included in
such Demand or Piggyback Registration exceeds the amount which can be sold in (or during the time of) such offering without adversely affecting the marketability of the offering (including the price per share or the number of securities to be sold),
then, after including all shares proposed to be sold by the Company in a Company-initiated registration or all shares proposed to be sold by the holders participating in a secondary registration on behalf of other holders of the Company’s
securities, the amount of securities to be offered for the account of the requesting Holders shall be reduced pro rata among the Holders participating in such offering on the basis of the number of Registrable Securities owned by each such Holder.

  

 3 

 (c) Each Holder agrees to furnish to the Company a signed and completed Notice and Questionnaire in the
form attached to this Agreement as Annex A (a “Selling Holder Questionnaire”) not less than seven (7) Trading Days prior to the proposed filing date of the Registration Statement. Notwithstanding anything to the contrary
contained in this Agreement, no Holder shall be entitled to be named as a selling stockholder in the Registration Statement as of the effective time thereof, and no Holder shall be entitled to use the Prospectus forming a part thereof for offers and
resales of Registrable Securities at any time, unless such Holder has returned a properly completed and signed Selling Stockholder Questionnaire to the Company by the deadline for response set forth in the foregoing sentence. Any Holder of
Registrable Securities that has returned a properly completed and signed Selling Holder Questionnaire to the Company within the deadline set forth above shall be referred to as an “Electing Holder.” In addition, if a Holder fails to
furnish any information to the Company within five (5) Trading Days after a written request from the Company for such information, such Holder’s name may be removed or excluded from the Registration Statement or Prospectus forming a part
thereof. 
 4. Registration Procedures. 
 In connection with the Company’s registration obligations hereunder, the Company shall: 
 (a) Not less
than ten (10) Trading Days prior to the initial filing of the Registration Statement or any related Prospectus, and not less than three (3) Trading Days prior to the filing of any amendment or supplement thereto, furnish to each Holder
copies of all such documents proposed to be filed with the Commission (including documents incorporated or deemed incorporated by reference to the extent requested by such Person), which documents will be subject to the review and comment of such
Holders; 
 (b) Prepare and file with the Commission such amendments, including post-effective amendments, to the Registration Statement and
the Prospectus used in connection therewith as may be necessary to keep the Registration Statement effective as to the applicable Registrable Securities until the expiration of the Effectiveness Period (as defined in the next sentence). With respect
to a Registration Statement, the term “Effectiveness Period” shall mean the first to occur of (i) the date that all Registrable Securities included in the Registration Statement may be sold in compliance with Rule 144(k) under the
Securities Act, (ii) the date that the Holders have sold all Registrable Securities included in the Registration Statement (pursuant to the Registration Statement or otherwise), (iii) the date that all Registrable Securities included in
the Registration Statement are no longer outstanding; or (iv) the date that is two years after the effective date of the Registration Statement. 
 (c) Cause the related Prospectus to be amended or supplemented by any required supplement, which supplement shall be filed with the Commission pursuant to Rule 424 if required by such rule; 
 (d) Respond as promptly as reasonably possible to any comments received from the Commission with respect to the Registration Statement or any amendment
thereto and, within a reasonable period of time, upon request of a Holder, provide such Holder with a true and complete copy of all correspondence from and to the Commission relating to the Registration Statement; 
  

 4 

 (e) Use its reasonable best efforts to comply with all applicable rules and regulations of the Commission
related to the registration of the Registrable Securities; 
 (f) Notify the Electing Holders as promptly as reasonably possible
(i) when the Registration Statement or any post-effective amendment has become effective; (ii) of any request by the Commission or any other Federal or state governmental authority during the period of effectiveness of the Registration
Statement for amendments or supplements to the Registration Statement or Prospectus or for additional information; (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the
effectiveness of the Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose; (iv) of the receipt by the Company of any notification with respect to the suspension of the
qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and (v) of the happening of any event (or the passage of time,
or both) as a result of which (A) the Prospectus included in the Registration Statement (or any document incorporated or deemed to be incorporated therein by reference) contains an untrue statement of a material fact or omits any fact necessary
to make the statements therein, in light of the circumstances under which they were made, not misleading, (B) the financial statements contained therein are ineligible to be relied upon or included therein for any reason, or (C) any
statement made in the Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference is required to be revised so that the Registration Statement or the Prospectus will not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; 
 (g) Use commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order suspending the effectiveness
of the Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment; 
 (h) Promptly deliver to each Electing Holder, without charge, as many copies of the Prospectus or Prospectuses (including each form of prospectus) and
each amendment or supplement thereto as such Electing Holder may reasonably request in connection with resales of Registrable Securities by the Electing Holder. Subject to the terms of this Agreement, the Company hereby consents to the use of such
Prospectus and each amendment or supplement thereto by each of the selling Electing Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto, except after the
giving on any notice pursuant to Section 4(f). 
 (i) Prior to any resale of Registrable Securities by an Electing Holder, use its
commercially reasonable efforts to register by coordination or cooperate with the selling Electing Holders in connection with the registration (or exemption from the Registration) of such Registrable Securities for the resale by the Holder under the
securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep the registration (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or
things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by the Registration Statement; provided, that the Company shall not be required to qualify generally to do business in any jurisdiction
where it is not then so qualified, subject the Company to any tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such jurisdiction. 
  

 5 

 (j) If requested in writing by the Electing Holders, cooperate with the Electing Holders to facilitate
the timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to the Registration Statement, which certificates shall be free, to the extent permitted by the Purchase Agreement, of
all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holders may so request. 
 (k) Upon the occurrence of any event contemplated by Section 4(f)(v), as promptly as reasonably possible, prepare a supplement or amendment, including a post-effective amendment, to the Registration Statement or
a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither the Registration Statement nor such Prospectus will
contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. If the Company
notifies the Electing Holders in accordance with clauses (ii) through (v) of Section 4(f) above to suspend the use of any Prospectus, then the Electing Holders shall suspend use of such Prospectus. The Company will use its
commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. 
 5. Registration
Expenses. All fees and expenses incident to the performance of or compliance with this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are sold pursuant to the Registration Statement. The fees and
expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses (A) with respect to filings required to be made with the Trading
Market on which the Common Stock is then listed for trading, and (B) in compliance with applicable state securities or Blue Sky laws), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable
Securities and of printing prospectuses if the printing of prospectuses is reasonably requested by the holders of a majority of the Registrable Securities included in the Registration Statement), (iii) messenger, telephone and delivery
expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection
with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement
(including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable
Securities on any securities exchange as required hereunder. Except as provided in any of the Transaction Documents, in no event shall the Company be responsible for any broker or similar commissions or, except to the extent provided for in the
Transaction Documents, any legal fees or other costs of the Holders. 
  

 6 

 6. Indemnification. 
 (a) Indemnification by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the officers, directors, agents and employees of each of them,
each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, agents and employees of each such controlling Person, to the fullest extent
permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of or
relating to any untrue or alleged untrue statement of a material fact contained in the Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or
relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in light of the circumstances under
which they were made) not misleading, except to the extent, but only to the extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished to the Company by such Holder expressly for use
therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved by the Holder for use in the Registration Statement, such Prospectus
or such form of Prospectus or in any amendment or supplement thereto (it being understood that the Holders have approved the contents of Annex B hereto for this purpose); (ii) (A) the use or attempted use by such Holder of a
Prospectus at any time that the Holder is not permitted to use such Prospectus, or (B) in the case of an occurrence of an event of the type specified in Section 4(f)(ii)-(v), any use or attempted use of the Prospectus by the Holder after
the Company has notified such Holder in writing of the suspension of the Prospectus and prior to the receipt by such Holder of the Advice contemplated in Section 7(d); or (iii) the failure of any Holder to comply with the prospectus
delivery requirements of the securities laws. The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding of which the Company is aware in connection with the transactions contemplated by this Agreement.

 (b) Indemnification by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its
directors, officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, agents or employees of such
controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: (i) such Holder’s failure to comply with the prospectus delivery
requirements of the Securities Act, (ii) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, or any form of prospectus, or in any amendment or supplement thereto or in any
preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading (A) to the extent, but only to the extent,
that such untrue statement or omission is contained in any information so furnished to the Company by the Holder specifically for inclusion in the Registration Statement or such Prospectus or (B) to the extent that such untrue statements or
omissions are based solely upon information regarding such Holder furnished to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution
of Registrable Securities and was reviewed and approved by the Holder for use in the Registration Statement (it being understood that the Holders have approved Annex B hereto for this purpose), such Prospectus or such form 

  

 7 

 
of Prospectus or in any amendment or supplement thereto; (iii) the use or attempted use by such Holder of a Prospectus at any time that the Holder is
not permitted to use such Prospectus; or (iv) in the case of an occurrence of an event of the type specified in Section 4(f)(ii)-(v), use or attempted use of the Prospectus by the Holder after the Company has notified such Holder in
writing of the suspension and prior to the receipt by such Holder of the Advice contemplated in Section 7(d). In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of the net proceeds
received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation. 
 (c) Conduct of
Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity
is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all
fees and expenses incurred in connection with defense thereof; provided, that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and
only) to the extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have prejudiced the Indemnifying Party. 
 An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees and
expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing to pay such fees and expenses; (2) the Indemnifying Party shall have failed promptly to assume
the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party
and the Indemnifying Party, and a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in
writing that it elects to employ separate counsel reasonably satisfactory to the Indemnifying Party at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable fees and
expenses of one separate counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably
withheld. No Indemnifying Party shall, without the prior written consent of the Indemnified Party which consent shall not be unreasonably withheld, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party,
unless such settlement includes an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding. 
 (d) Contribution. If a claim for indemnification under Section 6(a) or 6(b) is unavailable to an Indemnified Party (by reason of public policy or otherwise), then each Indemnifying Party, in lieu of
indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified
Party in connection with the actions, statements or omissions that resulted in such Losses as well as any 

  

 8 

 
other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other
things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party
or Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed
to include, subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for
such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms. 
 (e)
The parties hereto agree that it would not be just and equitable if contribution pursuant to Section 6(d) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations
referred to in the immediately preceding paragraph. Notwithstanding the provisions of this Section 6(e), no Holder shall be required to contribute, in the aggregate, any amount in excess of the amount by which the proceeds actually received by
such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission, except in the case of fraud by such Holder. 
 (f) The indemnity and contribution agreements contained in this Section are in
addition to any liability that the Indemnifying Parties may have to the Indemnified Parties. 
 7. Miscellaneous. 
 (a) Remedies. In the event of a breach by the Company or by a Holder, of any of their obligations under this Agreement, each Holder or the Company,
as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, will be entitled to specific performance of its rights under this Agreement. The Company and each Holder
agree that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in
respect of such breach, it shall waive the defense that a remedy at law would be adequate. 
 (b) Compliance. Each Holder covenants
and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to it in connection with sales of Registrable Securities pursuant to the Registration Statement. 
 (c) Discontinued Disposition. Each Electing Holder agrees by its acquisition of such Registrable Securities that, upon receipt of a notice from
the Company of the occurrence of any event of the kind described in Section 4(f), such Electing Holder will forthwith discontinue disposition of such Registrable Securities under the Registration Statement until such Electing Holder’s
receipt of the copies of the supplemented Prospectus and/or amended Registration Statement or until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus may be resumed, and, in either
case, has received copies of any 

  

 9 

 
additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such Prospectus or Registration Statement. The Company
will use its commercially reasonable efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. 
 (d)
Amendments and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the
same shall be in writing and signed by the Company and Holders of at least 50% of the then-outstanding Registrable Securities, unless the waiver or consent effects only the waiving or consenting of one or more particular Holders, in which case such
waiver or consent need only be signed by such Holder or Holders. 
 (e) Notices. Any and all notices or other communications or
deliveries required or permitted to be provided hereunder shall be made in accordance with the provisions of the Purchase Agreement. Notwithstanding the foregoing, each Holder acknowledges that any communications or deliveries required to be made to
a Holder hereunder may be made by e-mail or other electronic means. 
 (f) Successors and Assigns. This Agreement shall inure to the
benefit of and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. Each Holder may assign their respective rights hereunder in the manner and to the Persons as permitted under
the Purchase Agreement, subject to applicable law. 
 (g) Execution and Counterparts. This Agreement may be executed in any number of
counterparts, each of which when so executed shall be deemed to be an original and, all of which taken together shall constitute one and the same Agreement. In the event that any signature is delivered by facsimile transmission, such signature shall
create a valid binding obligation of the party executing (or on whose behalf such signature is executed) the same with the same force and effect as if such facsimile signature were the original thereof. 
 (h) Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined with
the provisions of the Purchase Agreement. 
 (i) Cumulative Remedies. The remedies provided herein are cumulative and not exclusive of
any remedies provided by law. 
 (j) Severability. If any term, provision, covenant or restriction of this Agreement is held by a
court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or
invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction.
It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable. 
  

 10 

 (k) Headings. The headings in this Agreement are for convenience of reference only and shall not
limit or otherwise affect the meaning hereof. 
 (l) Independent Nature of Holders’ Obligations and Rights. The obligations of
each Holder hereunder are several and not joint with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder hereunder. Nothing contained herein or in
any other agreement or document delivered at any closing, and no action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other kind of entity, or
create a presumption that the Holders are in any way acting in concert with respect to such obligations or the transactions contemplated by this Agreement. Each Holder shall be entitled to protect and enforce its rights, including without limitation
the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. 
 *  *   * 
  

 11 

 IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first
written above. 
  

			
	SYNOVA HEALTHCARE GROUP, INC.
		
	 By:
	 	  

	Name:	 	Stephen E. King
	Title:	 	Chairman and Chief Executive Officer

 [SIGNATURE PAGE OF HOLDER(S) FOLLOWS] 
  

 12 

 [PURCHASER’S SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT] 
 Name of Purchaser: 
 Signature of Authorized Signatory of Purchaser: _________________________________________________ 
 Name of Authorized Signatory: ______________________________________________________________ 
 Title of Authorized
Signatory: _______________________________________________________________ 
  

 13 

 ANNEX A 
 Synova Healthcare Group, Inc. 
 Selling Securityholder Notice and Questionnaire 
 The undersigned beneficial owner of common stock, par value $0.001 per share (the “Common Stock”), of Synova Healthcare Group, Inc., a
Nevada corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a
registration statement (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance
with the terms of the undersigned’s Registration Rights Agreement (the “Registration Rights Agreement”), among the Company and the Purchasers named therein. A copy of the Registration Rights Agreement is available from the
Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement. 
 In order to have Registrable Securities included in the Registration Statement (or a supplement or amendment thereto), this Selling Securityholder Notice
and Questionnaire (“Selling Securityholder Questionnaire”) must be completed, executed and delivered to the Company at the address set forth herein for receipt AS SOON AS POSSIBLE BUT IN NO EVENT AFTER
                        , 200  . Record or beneficial owners of Registrable Securities who do not
properly complete, execute and return this Selling Securityholder Questionnaire by such dates (i) will not be named as selling securityholders in the Registration Statement and (ii) may not use the Prospectus forming a part thereof for
resales of Registrable Securities. 
 Certain legal consequences arise from being named as a selling securityholder in the
Registration Statement and the related prospectus. Accordingly, holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling
securityholder in the Registration Statement and the related prospectus. 
 NOTICE 
 The undersigned beneficial owner (the “Selling Securityholder”) of Registrable Securities hereby elects to include the Registrable
Securities owned by him/it and listed below in Item 3 (unless otherwise specified under such Item 3) in the Registration Statement. The undersigned, by signing and returning this Selling Securityholder Questionnaire, agrees to be bound
with respect to such Registrable Securities by the terms and conditions of this Selling Securityholder Questionnaire and the Registration Rights Agreement, as if the undersigned Selling Securityholder were an original party thereto. 
 Upon any sale of Registrable Securities pursuant to the Registration Statement, the Selling Securityholder will be required to deliver to the Company the
Notice of Transfer (completed and signed) set forth in Exhibit 1 to this Selling Securityholder Questionnaire. 
  

 14 

 The undersigned hereby provides the following information to the Company and represents and warrants that
such information is accurate and complete: 
 QUESTIONNAIRE 
  

	 	1.	Name. 

  

	 	(a)	Full Legal Name of Selling Securityholder 

                                       
                                        
                                        
                                        
                                        
                                
  

	 	(b)	Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities Listed in Item 3 below are held: 

                                       
                                        
                                        
                                        
                                        
                                
  

	 	(c)	Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by the
questionnaire): 

  

	 	2.	Address for Notices to Selling Securityholder: 

                                       
                                        
                                        
                                        
                                        
                                        

                                       
                                        
                                        
                                        
                                        
                                        

 Telephone: __________________________________________________________________________________________________ 
       E-mail: 
       Fax: 
       Contact Person: __________________________________________________________________________________________ 
  

 15 

	 	3.	Beneficial Ownership of Securities: 

 Except as set
forth below in this Item (3), the undersigned Selling Securityholder does not beneficially own any securities of the Company or shares of Common Stock that may be issued upon the exercise or conversion of any securities of the Company. 

 

	 	(a)	Number of Registrable Securities (as defined in the Registration Rights Agreement) beneficially owned: 

                                       
                                        
                                        
                                        
                                        
                                
                                       
                                        
                                        
                                        
                                        
                                
 Number of Registrable Securities (if any) that may be issued upon the exercise or conversion of securities: ____________ 
  

	 	(b)	Number of securities other than Registrable Securities beneficially owned: 

                                       
                                        
                                        
                                        
                                        
                                
                                       
                                        
                                        
                                        
                                        
                                
 Number of securities other than Registrable Securities (if any) that may be issued upon the exercise or conversion of securities:____________

  

	 	(c)	Number of Registrable Securities to be included in the Registration Statement: ______________________________ 

                                       
                                        
                                        
                                        
                                        
                                
                                       
                                        
                                        
                                        
                                        
                                
 Number of Registrable Securities (if any) that may be issued upon the exercise or conversion of securities, which Registrable Securities are to be
included in the Registration Statement: ___________________________________ 
  

	 	4.      (a)	State whether the undersigned Selling Securityholder has or will enter into “hedging transactions” with respect to shares of Company Common Stock.

 Yes     ̈    No     ̈ 
 If yes, you must provide a complete description of the hedging transactions into which the undersigned Selling Securityholder has entered or will enter and the purpose of such hedging transactions, the extent to which
such hedging transactions remain in place. 
                                       
                                        
                                        
                                        
                                        
                                
                                       
                                        
                                        
                                        
                                        
                                
  

 16 

 Please note that the Commission may deem short sales of securities covered by a registration statement
prior to the effectiveness of such registration statement as a violation of Section 5 of the Securities Act. 
  

	 	(b)	State whether the undersigned Selling Securityholder has sold any of the Registrable Securities or shares of common stock of the Company short since the date of original issuance of
the Registrable Securities. 

 Yes     ̈    No     ̈ 
 If yes, you must provide a complete description of the short sale, including the number of shares of common stock of the Company involved and whether
the short position remains in place. 
                                       
                                        
                                        
                                        
                                        
                                
                                       
                                        
                                        
                                        
                                        
                                
                                       
                                        
                                        
                                        
                                        
                                
                                       
                                        
                                        
                                        
                                        
                                
  

	 	5.	Broker-Dealer Status: 

  

	 	(a)	Are you a broker-dealer? 

 Yes     ̈    No     ̈ 
  

	 	Note:	If yes, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement. 

  

	 	(b)	Are you an affiliate of a broker-dealer? 

 Yes     ̈    No     ̈ 
  

	 	(c)	If you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the ordinary course of business, and at the time of the purchase of the
Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities? 

 Yes     ̈    No     ̈ 
  

	 	Note:	If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement. 

  

 17 

	 	(d)	State whether the undersigned Selling Securityholder received Registrable Securities as compensation for underwriting activities and p lease explain. 

 Yes     ̈    No     ̈ 
  

	 	6.	Relationships with the Company: 

 Except as set
forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material
relationship with the Company (or its predecessors or affiliates) during the past three years. 
 State any exceptions here: 

 
 By signing below, the Selling Securityholder acknowledges that it understands
its obligation to comply, and agrees that it will comply, with the prospectus delivery and other provisions of the Securities Act and the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, particularly Regulation
M. 
 In the event that the Selling Securityholder transfers all or any portion of the Registrable Securities listed in Item (3) above
after the date on which such information is provided to the Company, the Selling Securityholder agrees to notify the transferee(s) of its rights and obligations under this selling Securityholder Questionnaire and the Registration Rights Agreement.

 By signing below, the Selling Securityholder consents to the disclosure of the information contained herein in its answers to Items
(1) through (6) above and the inclusion of such information in the Registration Statement and related Prospectus. The Selling Securityholder understands that such information will be relied upon by the Company in connection with the
preparation of the Registration Statement and related Prospectus. 
 In accordance with the Selling Securityholder’s obligations under
the Registration Rights Agreement to provide such information as may be required by law for inclusion in the Registration Statement, the Selling Securityholder agrees to promptly notify the Company of any inaccuracies or changes in the information
provided herein which may occur subsequent to the date hereof at any time while the Registration Statement remains in effect and to provide any additional information as the Company reasonably may request. Except as otherwise provided in the
Registration Rights Agreement, all notices hereunder and pursuant to the Registration Rights 

  

 18 

 
Agreement shall be made in writing, by hand-delivery, first-class mail, or air courier guaranteeing overnight delivery as follows: 
  

	 	(i)	To the Company: 

 Synova Healthcare Group,
Inc. 
 Rose Tree Corporate Center 
 1400 N. Providence Road 
 Suite 6010, Building II 
 Media, PA 19063 
 Attention: Stephen King 
  

	 	(ii)	With a copy to: 

 Blank Rome LLP

 One Logan Square 
 Philadelphia, PA 19103 
 Attention: Jeffrey M. Taylor, Esquire 
 Once this Notice and Questionnaire is executed by the Selling Securityholder and received by the Company, the terms of this Selling Securityholder
Questionnaire, and the representations and warranties contained herein, shall be binding on, shall inure to the benefit of and shall be enforceable by the respective successors, heirs, personal representatives, and assigns of the Company and the
Selling Securityholder (with respect to the Registrable Securities beneficially owned by such Selling Securityholder and listed in Item (3) above). This Agreement shall be governed in all respects by the laws of the State of Delaware.

  

 19 

 IN WITNESS WHEREOF, the undersigned, by authority duly given, has caused this Selling
Securityholder Questionnaire to be executed and delivered either in person or by its duly authorized agent. 
  

					
	Dated:	 	Selling Securityholder (Print/type full legal name of beneficial owner of Registrable Securities)
			
		 	By:	 	  

		 		 	Name:
		 		 	Title:

 PLEASE RETURN THE COMPLETED AND EXECUTED SELLING SECURITYHOLDER QUESTIONNAIRE FOR RECEIPT AS
SOON AS POSSIBLE BUT IN NO EVENT LATER THAN                             , 200  
TO THE COMPANY AT: 
 Synova Healthcare Group, Inc. 
 Rose Tree Corporate Center 
 1400 N. Providence Road 
 Suite 6010, Building II 
 Media, PA 19063 
 Attention: Stephen E. King, Chairman and CEO 
 With a copy to: 
 Blank Rome LLP 
 One Logan Square 
 Philadelphia, Pennsylvania 19103 
 Attention: Jeffrey M. Taylor, Esquire 
  

 20 

 Exhibit 1 to Selling Securityholder Questionnaire 
 NOTICE OF TRANSFER PURSUANT TO REGISTRATION STATEMENT 
 Synova Healthcare Group, Inc. 
 Rose Tree Corporate Center 
 1400 N. Providence Road 
 Suite 6010, Building II 
 Media, PA 19063 
 Attention: Stephen King 
  

	 	Re:	Synova Healthcare Group, Inc. (the “Company”) 

	 	    	Common Stock, par value $.001 per share (the “Stock”) 

 Dear Sirs: 
 Please be advised that
                                        
has transferred                      shares of the Company’s common stock pursuant to an effective Registration Statement on Form SB-2
(File No. 333-          ) filed by the Company. 
 We hereby certify that the
prospectus delivery requirements, if any, of the Securities Act of 1933, as amended, have been satisfied with respect to the transfer described above and that the above-named beneficial owner of the common stock is named as a selling securityholder
in the Prospectus dated                         , 200   or in amendments or supplements thereto, and the
number of shares of common stock transferred are [a portion of] the shares of common stock listed in such Prospectus, as amended or supplemented, opposite such owner’s name. 
 Dated: 
  

			
	Very truly yours,
	(Name)
		
	By:	 	  

	(Authorized Signature)

  

 21 

 ANNEX B 
 PLAN OF DISTRIBUTION 
  

 22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}]]